4th Quarter - Report — SEQIRUS for SEQIRUS (2024)

Firm

SEQIRUS

Client

SEQIRUS

Income

—

Expenses

$220,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY2025 Appropriations and supplemental appropriations, policies related to pandemic preparedness and public health; FY2025 President's Budget proposals, policies related to pandemic preparedness and public health; HR 5846, Protecting America from Seasonal and Pandemic Influenza Act of 2023; S 3219, Influenza Act; FY2025 NDAA; Pandemic and All-Hazards Preparedness Reauthorization.

Foreign entity interest: CSL Limited, identified on Registration (LD-1), is the parent company of Seqirus and benefits from the financial success thereof.

Lobbyist	Covered position, as disclosed
CHRISTINE FARQUHARSON	—

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE

Bills named: H.R. 5846 (118th)

Health Issues HCR

Foreign entity interest: CSL Limited, identified on Registration (LD-1), is the parent company of Seqirus and benefits from the financial success thereof.

Lobbyist	Covered position, as disclosed
CHRISTINE FARQUHARSON	—

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB)

Bills named: H.R. 5846 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.